4,5-Dimethoxy-1-Cyanobenzocyclobutane CAS 35202-54-1 Pite > 99.0% (HPLC) Ivabradine Hydrochloride Entèmedyè Faktori
Ruifu Chimik Pwovizyon pou Ivabradine Hydrochloride Entèmedyè ak Pite segondè
Ivabradine Hydrochloride CAS 148849-67-6
4,5-Dimethoxy-1-Cyanobenzocyclobutane CAS 35202-54-1
(1S) -4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride CAS 866783-13-3
7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-yon CAS 73942-87-7
7,8-Dimethoxy-3-(3-yodopropyl)-1,3-dihydro-2H-3-benzazepin-2-yon CAS 148870-57-9
3-(3-Chloropropyl)-7,8-dimethoxy-1H-3-benzazepin-2(3H)-yon CAS 85175-59-3
Non Chimik | 4,5-Dimethoxy-1-Cyanobenzocyclobutane |
Sinonim | 4,5-Dimethoxy-1-Benzocyclobutenecarbonitrile;1-Cyano-4,5-Dimethoxybenzocyclobutene;3,4-Dimethoxybicyclo [4.2.0] octa-1,3,5-triene-7-Carbonitrile;Ivabradine Hydrochloride Entèmedyè |
Nimewo CAS | 35202-54-1 |
Nimewo CAT | RF-PI1809 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C11H11NO2 |
Pwa molekilè | 189.21 |
Pwen k ap fonn | 83.0 ~ 84.0 ℃ |
Dansite | 1.18 |
Solibilite (Soluble nan) | Methanol |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Off-blan pou limyè mawon poud |
Idantifikasyon | HPLC/UV Konfòme |
Pite / Metòd analiz | >99.0% (HPLC) |
Pèt sou siye | <0.50% (Seche li nan 40 ℃ jiska pwa konstan) |
Rezid sou ignisyon | <0.10% |
Sibstans ki gen rapò | |
Enpurte endividyèl | <0.50% |
Enpurte total | <1.00% |
Metal lou | <10ppm |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè nan Ivabradine Hydrochloride (CAS: 148849-67-6) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
4,5-Dimethoxy-1-Cyanobenzocyclobutane (CAS: 35202-54-1) se yon entèmedyè nan Ivabradine Hydrochloride (CAS: 148849-67-6).Ivabradine Hydrochloride te evolye kòm yon inibitè espesifik nan If aktyèl atravè kontak li yo ak f-chanèl sou bò a intraselilè nan manbràn plasma a.Kòm yon konsekans, Ivabradine diminye vitès la nan depolarize dyastolik ak diminye batman kè.Li te apwouve pou tretman anjin kwonik ki estab epi li bay yon altènatif solid pou pasyan ki gen yon kontr oswa entolerans nan b-blockers.Evalyasyon tou sou pye pou tretman potansyèl maladi kè ischemic.